Stoewen Debbie L, Coe Jason B, MacMartin Clare, Stone Elizabeth A, Dewey Catherine E
Department of Population Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada.
J Am Vet Med Assoc. 2013 Nov 15;243(10):1415-25. doi: 10.2460/javma.243.10.1415.
To elucidate factors influencing practitioner decisions to refer dogs with cancer to veterinary oncology specialists.
Cross-sectional study.
2,724 Ontario primary care companion animal veterinarians.
Practitioners were invited to participate in a survey involving clinical scenarios of canine cancer patients, offered online and in paper format from October 2010 through January 2011. Analyses identified factors associated with the decision to refer patients to veterinary oncology specialists.
1,071 (39.3%) veterinarians responded, of which 603 (56.3%) recommended referral for dogs with multicentric lymphoma and appendicular osteosarcoma. Most (893/1,059 [84.3%]) practiced within < 2 hours' drive of a specialty referral center, and most (981/1,047 [93.7%]) were completely confident in the oncology service. Few (230/1,056 [21.8%] to 349/1,056 [33.0%]) were experienced with use of chemotherapeutics, whereas more (627/1,051 [59.7%]) were experienced with amputation. Referral was associated with practitioner perception of patient health status (OR, 1.54; 95% confidence interval [CI], 1.15 to 2.07), the interaction between the client's bond with the dog and the client's financial status, practitioner experience with treating cancer (OR, 2.79; 95% CI, 1.63 to 4.77), how worthwhile practitioners considered treatment to be (OR, 1.66 to 3.09; 95% CI, 1.08 to 4.72), and confidence in the referral center (OR, 2.20; 95% CI, 1. 11 to 4.34).
Several factors influenced practitioner decisions to refer dogs with lymphoma or osteosarcoma for specialty care. Understanding factors that influence these decisions may enable practitioners to appraise their referral decisions and ensure they act in the best interests of patients, clients, and the veterinary profession.
阐明影响兽医将患癌犬只转诊至兽医肿瘤学专家的因素。
横断面研究。
2724名安大略省的初级保健伴侣动物兽医。
邀请从业者参与一项涉及犬类癌症患者临床病例的调查,于2010年10月至2011年1月以在线和纸质形式提供。分析确定了与将患者转诊至兽医肿瘤学专家的决定相关的因素。
1071名(39.3%)兽医做出回应,其中603名(56.3%)建议将患有多中心淋巴瘤和附肢骨肉瘤的犬只转诊。大多数(893/1059 [84.3%])在距离专科转诊中心不到2小时车程的范围内执业,并且大多数(981/1047 [93.7%])对肿瘤学服务完全有信心。很少有人(230/1056 [21.8%]至349/1056 [33.0%])有使用化疗药物的经验,而更多人(627/1051 [59.7%])有截肢经验。转诊与从业者对患者健康状况的认知相关(比值比[OR],1.54;95%置信区间[CI],1.15至2.07)、客户与犬只的关系以及客户财务状况之间的相互作用、从业者治疗癌症的经验(OR,2.79;95%CI,1.63至4.77)、从业者认为治疗的价值(OR,1.66至3.09;95%CI,1.08至4.72)以及对转诊中心的信心(OR,2.20;95%CI,1.11至4.34)。
有几个因素影响从业者将患有淋巴瘤或骨肉瘤的犬只转诊至专科护理的决定。了解影响这些决定的因素可能使从业者能够评估他们的转诊决定,并确保他们为患者、客户和兽医行业的最佳利益行事。